C. Kauffman

Publications504
h-index88
Citations39,286
Highly Influential Citations1,605
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • T. Walsh
  • 993 Publications, 66,790 Citations
  • M. Pfaller
  • 872 Publications, 72,758 Citations
  • D. Kontoyiannis
  • 712 Publications, 38,638 Citations
  • P. Pappas
  • 258 Publications, 28,763 Citations
  • Publications
  • Influence
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy…
BACKGROUND Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical… Expand
  • 3,498
  • 181
  • PDF
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines… Expand
  • 2,820
  • 178
  • PDF
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or… Expand
  • 1,336
  • 104
  • PDF
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
BACKGROUND The incidence and severity of herpes zoster and postherpetic neuralgia increase with age in association with a progressive decline in cell-mediated immunity to varicella-zoster virus… Expand
  • 1,488
  • 66
  • PDF
Histoplasmosis: a Clinical and Laboratory Update
  • C. Kauffman
  • Medicine
  • Clinical Microbiology Reviews
  • 1 January 2007
SUMMARY Infection with Histoplasma capsulatum occurs commonly in areas in the Midwestern United States and Central America, but symptomatic disease requiring medical care is manifest in very few… Expand
  • 811
  • 62
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
BACKGROUND Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and… Expand
  • 948
  • 56
  • PDF
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET)…
BACKGROUND The incidence and epidemiology of invasive fungal infections (IFIs), a leading cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived mainly from… Expand
  • 1,022
  • 55
  • PDF
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.
Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the… Expand
  • 835
  • 48
  • PDF
Voriconazole: a new triazole antifungal agent.
Voriconazole is a second-generation azole antifungal agent that shows excellent in vitro activity against a wide variety of yeasts and molds. It can be given by either the intravenous or the oral… Expand
  • 667
  • 33
  • PDF
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Getting HIV Under Control Approximately 1 in 300 people infected with HIV are HIV “controllers” who are able to maintain long-term control of the virus without medication and who do not progress to… Expand
  • 966
  • 29